Xin Lang Zheng Quan·2025-11-07 05:52Core Viewpoint - Spring Medical experienced a stock price decline of 2.13% on November 7, with a current price of 26.69 CNY per share and a market capitalization of 10.237 billion CNY [1] Company Overview - Beijing Spring Lida Medical Devices Co., Ltd. was established on February 12, 1998, and went public on December 30, 2021. The company specializes in the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2] - The main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems. The products are exported to various regions including Asia, South America, Africa, Oceania, and Europe [2] - The revenue composition is primarily from medical device products (99.89%) with a minor contribution from other sources (0.11%) [2] Financial Performance - For the period from January to September 2025, Spring Medical reported a revenue of 755.6 million CNY, representing a year-on-year growth of 48.75%. The net profit attributable to the parent company was 192 million CNY, showing a significant increase of 213.21% year-on-year [2] - Since its A-share listing, the company has distributed a total of 359 million CNY in dividends, with 309 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 4.12% to 6,164, while the average number of circulating shares per person decreased by 3.95% to 46,906 shares [2] - Notable institutional shareholders include Hong Kong Central Clearing Limited, which is the fourth-largest shareholder with 2.9585 million shares, and China Europe Economic Growth Mixed Fund A, which is the fifth-largest with 2.8326 million shares, both being new shareholders [3]